What did @coachdarianbates actually say?
The creator laid out a tiered approach to estrogen (referred to throughout as "ETG," likely meaning estradiol) management on testosterone. The core argument: keep estradiol "as high as possible" without side effects, try lifestyle and dose adjustments before reaching for an aromatase inhibitor, and if gynecomastia is already developing, use "moxamine citrate" (almost certainly tamoxifen citrate) short-term before tapering off.
The video also listed side effects of both high and low estradiol, named Masteron (drostanolone) as an option for modulating the androgen-to-estrogen ratio, and cautioned against jumping straight to aromatase inhibitors. The general framework is more nuanced than most TikTok hormone content, which usually defaults to "just take an AI." That said, several specific claims deserve scrutiny.
Does the science back this up?
Mostly, yes, with real caveats. The physiological case for maintaining estradiol within a functional range in men on TRT is well-supported. A 2013 study by Finkelstein et al. in the New England Journal of Medicine showed estrogen deficiency, not just testosterone deficiency, drives fat accumulation, low libido, and sexual dysfunction in men. The creator's instinct to avoid crashing estradiol is correct.
The reference range cited, "20 to 55 pgr per milliliter," roughly aligns with standard serum estradiol reference ranges for men (typically 10-40 pg/mL on standard assays, up to around 42 pg/mL on sensitive LC-MS/MS assays). The upper bound of 55 pg/mL is slightly generous but not wildly off for men on supraphysiologic testosterone.
The recommendation to try dose reduction before adding an aromatase inhibitor is supported by clinical practice guidelines. The Endocrine Society's 2018 TRT guidelines caution against routine AI use given risks of over-suppression. Citing Masteron as an androgen-to-estrogen modulator has a pharmacological rationale, though the evidence base is largely anecdotal and it is not an approved TRT adjunct.
What did they get wrong (or right)?
The biggest factual problem is calling the hormone "ETG" throughout. The standard clinical abbreviation is E2 (estradiol). This is likely just informal shorthand, but it introduces unnecessary confusion for viewers trying to interpret lab work.
"Rectal dysfunction" as a listed side effect of high estradiol is almost certainly a mispronunciation or verbal slip for "erectile dysfunction." Erectile dysfunction from elevated estradiol is a real, documented concern. Rectal dysfunction is not a recognized side effect. That kind of error in a video reaching nearly 20,000 viewers matters.
The tamoxifen recommendation is pharmacologically reasonable for early gynecomastia. A 2004 Cochrane review by Devalia et al. and subsequent studies support selective estrogen receptor modulators (SERMs) for treating gynecomastia. However, "moxamine citrate for a week or so" is vague, and the casual framing of "if you fucked up already" undersells how important timing is. SERMs work best on early glandular tissue, not established fibrotic gynecomastia. The "taper off" instruction implies a protocol the video never actually specifies.
Credit where it is due: the sequencing logic, lifestyle first, then dose adjustment, then consider an AI, is genuinely better advice than the reflexive AI use seen elsewhere in this content category.
What should you actually know?
Managing estradiol on TRT is not simple optimization math. The relationship between testosterone dose, aromatization, body fat percentage, and individual aromatase enzyme activity varies considerably between people. A 2019 analysis by Ramasamy et al. in the Journal of Urology found no clear universal threshold for symptomatic estradiol elevation in men on TRT.
Aromatase inhibitors carry real risks. Anastrozole and exemestane can over-suppress estradiol, causing bone density loss, joint pain, and lipid changes. These are not benign drugs to add casually. The creator's caution here is appropriate.
Masteron (drostanolone) is a controlled anabolic steroid, not an approved TRT medication. Recommending it as a tool for "modulating the antigen to ETG ratio" normalizes the use of performance-enhancing drugs in what is framed as a health context. Viewers should understand this is outside any regulated medical protocol.
If you are on TRT and concerned about estradiol, the right first step is a sensitive estradiol assay (LC-MS/MS), not a standard immunoassay, followed by a conversation with a prescribing clinician. Self-managing estradiol without lab confirmation is how people end up either crashing their levels or ignoring a genuine issue.